| Mary Margaret Gleason, MD | |
|
401 Gresham Dr, Norfolk, VA 23507 | |
| (577) 668-4673 | |
| Not Available |
| Full Name | Mary Margaret Gleason |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Child & Adolescent Psychiatry |
| Location | 401 Gresham Dr, Norfolk, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023136389 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0804X | Psychiatry & Neurology - Child & Adolescent Psychiatry | 0101268163 (Virginia) | Primary |
| 208000000X | Pediatrics | 0101268163 (Virginia) | Secondary |
| Entity Name | Childrens Specialty Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255354130 PECOS PAC ID: 5890788764 Enrollment ID: O20040406001195 |
News Archive
For the first time researchers investigate the molecular basis of memory in living mice.
XenoPort, Inc. announced today that it has initiated a Phase 2b clinical trial of arbaclofen placarbil (AP), also known as XP19986, in patients with gastroesophageal reflux disease (GERD) who remain symptomatic despite treatment with a proton pump inhibitor (PPI). The trial is a multi-center, randomized, double-blind, placebo-controlled study designed to assess the efficacy and safety of AP as adjunctive therapy to PPIs.
Sigma® Life Science, the innovative biological products and services brand of Sigma-Aldrich®, today announced that it has added 2,200 new Prestige Antibodies® powered by Atlas Antibodies to its industry-leading portfolio.
Comprehensive Care Corporation, which provides behavioral health, substance abuse and at-risk psychotropic pharmacy management services for managed care companies throughout the U.S. and Puerto Rico, is pleased to announce that CompCare de Puerto Rico (CCPR) has completed its build out of a fully contracted and credentialed specialty behavioral health provider network to better serve its clients and insured Medicare and dual-eligible members across the Island of Puerto Rico.
Students who receive sexuality education, including refusal skills training, before college matriculation are at lower risk of experiencing sexual assault during college, according to new research published today in PLOS ONE.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mary Margaret Gleason, MD 401 Gresham Dr, Norfolk, VA 23507 Ph: (504) 988-4673 | Mary Margaret Gleason, MD 401 Gresham Dr, Norfolk, VA 23507 Ph: (577) 668-4673 |
News Archive
For the first time researchers investigate the molecular basis of memory in living mice.
XenoPort, Inc. announced today that it has initiated a Phase 2b clinical trial of arbaclofen placarbil (AP), also known as XP19986, in patients with gastroesophageal reflux disease (GERD) who remain symptomatic despite treatment with a proton pump inhibitor (PPI). The trial is a multi-center, randomized, double-blind, placebo-controlled study designed to assess the efficacy and safety of AP as adjunctive therapy to PPIs.
Sigma® Life Science, the innovative biological products and services brand of Sigma-Aldrich®, today announced that it has added 2,200 new Prestige Antibodies® powered by Atlas Antibodies to its industry-leading portfolio.
Comprehensive Care Corporation, which provides behavioral health, substance abuse and at-risk psychotropic pharmacy management services for managed care companies throughout the U.S. and Puerto Rico, is pleased to announce that CompCare de Puerto Rico (CCPR) has completed its build out of a fully contracted and credentialed specialty behavioral health provider network to better serve its clients and insured Medicare and dual-eligible members across the Island of Puerto Rico.
Students who receive sexuality education, including refusal skills training, before college matriculation are at lower risk of experiencing sexual assault during college, according to new research published today in PLOS ONE.
› Verified 8 days ago
Peter M Dozier, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 601 Childrens Ln, Norfolk, VA 23507 Phone: 757-668-8866 Fax: 757-668-8870 | |
Dr. Crystal Miller Proud, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 850 Southampton Ave, Norfolk, VA 23510 Phone: 757-668-9920 Fax: 757-668-9930 | |
James Richard Wyant, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 600 Gresham Dr Ste 8610, Norfolk, VA 23507 Phone: 757-252-9015 Fax: 757-510-9041 | |
Dr. Paul A Sayegh, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 825 Fairfax Ave, Suite 710, Norfolk, VA 23507 Phone: 757-446-5888 Fax: 757-446-5918 | |
Dr. Jerry H Morewitz, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 825 Fairfax Ave, Suite 710, Norfolk, VA 23507 Phone: 757-446-5888 Fax: 757-446-5918 | |
Dr. C. Arthur Nalls Iii, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 6353 Center Drive, Ste 204, Norfolk, VA 23502 Phone: 757-461-3313 Fax: 757-461-8363 |